Wnt-1 and Neu collaborate to induce mammary tumors in bitransgenic mice carrying both MMTV-Wnt-1 and MMTV-Neu. In this report, gene expression profiles were determined for tumors from these bitransgenic mice, and compared with expression profiles of tumors from mice singly transgenic for MMTV-Wnt-1 or MMTV-Neu. While very different from tumors arising in MMTV-Neu transgenic mice, tumors from these bitransgenic mice were found not to have identifiable differences from tumors from MMTV-Wnt-1 transgenic mice, using clustering and multidimensional scaling analyses (unsupervised and supervised), One-way Analysis of Variance (ANOVA), and two sample t test (the later two of which were combined with false discovery rate computation). These observations suggest that Wnt-1 is dominant over Neu in specifying mammary tumor expression profiles.
SorlieT., PerouC. M., TibshiraniR., AasT., GeislerS., JohnsenH., HastieT., EisenM. B., van de RijnM., JeffreyS. S., ThorsenT., QuistH., MateseJ. C., BrownP. O., BotsteinD., LonningP. Eystein, and Borresen-DaleA. L.Gene Expression Patterns of Breast Carcinomas Distinguish Tumor Subclasses with Clinical Implications. Proc Natl Acad Sci USA98, 10869–10874 (2001).
2.
PerouC. M., SorlieT., EisenM. B., van de RijnM., JeffreyS. S., ReesC. A., PollackJ. R., RossD. T., JohnsenH., AkslenL. A., FlugeO., PergamenschikovA., WilliamsC., ZhuS. X., LonningP. E., Borresen-DaleA. L., BrownP. O., and BotsteinD.Molecular Portraits of Human Breast Tumours. Nature406, 747–752 (2000).
3.
WeigeltB., HuZ., HeX., LivasyC., CareyL. A., EwendM. G., GlasA. M., PerouC. M., and Van't VeerL. J.Molecular Portraits and 70-gene Prognosis Signature are Preserved Throughout the Metastatic Process of Breast Cancer. Cancer Res65, 9155–9158 (2005).
4.
SotiriouC., NeoS. Y., McShaneL. M., KornE. L., LongP. M., JazaeriA., MartiatP., FoxS. B., HarrisA. L., and LiuE. T.Breast Cancer Classification and Prognosis Based on Gene Expression Profiles from a Population-based Study. Proc Natl Acad Sci USA100, 10393–10398 (2003).
5.
FarmerP., BonnefoiH., BecetteV., Tubiana-HulinM., FumoleauP., LarsimontD., MacgroganG., BerghJ., CameronD., GoldsteinD., DussS., NicoulazA. L., BriskenC., FicheM., DelorenziM., and IggoR.Identification of Molecular Apocrine Breast Tumours by Microarray Analysis. Oncogene24, 4660–4671 (2005).
6.
LiY. and RosenJ. M.Stem/Progenitor Cells in Mouse Mammary Gland Development and Breast Cancer. J Mammary Gland Biol Neoplasia10, 17–24 (2005).
7.
HennighausenL.Mouse Models for Breast Cancer. Breast Cancer Res2, 2–7 (2000).
8.
KavanaughC. J., DesaiK. V., CalvoA., BrownP. H., CouldreyC., LubetR., and GreenJ. E.Pre-clinical Applications of Transgenic Mouse Mammary Cancer Models. Transgenic Res11, 617–633 (2002).
9.
SiegelP. M., HardyW. R., and MullerW. J.Mammary Gland Neoplasia: Insights from Transgenic Mouse Models. Bioessays22, 554–563 (2000).
10.
HutchinsonJ. N. and MullerW. J.Transgenic Mouse Models of Human Breast Cancer. Oncogene19, 6130–6137 (2000).
11.
CardiffR. D., MoghanakiD., and JensenR. A.Genetically Engineered Mouse Models of Mammary Intraepithelial Neoplasia. J Mammary Gland Biol Neoplasia5, 421–437 (2000).
12.
DesaiK. V., XiaoN., WangW., GangiL., GreeneJ., PowellJ. I., DicksonR., FurthP., HunterK., KucherlapatiR., SimonR., LiuE. T., and GreenJ. E.Initiating Oncogenic Event Determines Geneexpression Patterns of Human Breast Cancer Models. Proc Natl Acad Sci USA99, 6967–6972 (2002).
13.
FargianoA. A., DesaiK. V., and GreenJ. E.Interrogating Mouse Mammary Cancer Models: Insights from Gene Expression Profiling. J Mammary Gland Biol Neoplasia8, 321–334 (2003).
14.
GreenJ. E., DesaiK., YeY., KavanaughC., CalvoA., and HuhJ. I.Genomic Approaches to Understanding Mammary Tumor Progression in Transgenic Mice and Responses to Therapy. Clin Cancer Res10, 385S–390S (2004).
15.
HuangS., LiY., ChenY., PodsypaninaK., ChamorroM., OlshenA. B., DesaiK. V., TannA., PetersenD., GreenJ. E., and VarmusH. E.Changes in Gene Expression During the Development of Mammary Tumors in MMTV-Wnt-1 Transgenic Mice. Genome Biol6, R84 (2005).
16.
LiuE. T.Classification of Cancers by Expression Profiling. Curr Opin Genet Dev13, 97–103 (2003).
17.
PodsypaninaK., LiY., and VarmusH.Evolution of Somatic Mutations in Mammary Tumors in Transgenic Mice is Influenced by the Inherited Genotype. BMC Medicine2, 24 (2004).
18.
LiY., WelmB., PodsypaninaK., HuangS., ChamorroM., ZhangX., RowlandsT., EgebladM., CowinP., WerbZ., TanL. K., RosenJ. M., and VarmusH. E.Evidence that Transgenes Encoding Components of the Wnt Signaling Pathway Preferentially Induce Mammary Cancers from Progenitor Cells. Proc Natl Acad Sci USA100, 15853–15858 (2003).
19.
Expression profiling-Best Practices for Data Generation and Interpretation in Clinical Trials. Nat Rev Genet5, 229–237 (2004).
20.
LiC. and WongW. H.Model-based Analysis of Oligonucleotide Arrays: Expression Index Computation and Outlier Detection. Proc Natl Acad Sci USA98, 31–36 (2001).
21.
LiC. and WongW. HungModel-based Analysis of Oligonucleotide Arrays: Model Validation, Design Issues and Standard Error Application. Genome Biol2, RESEARCH0032 (2001).
22.
YangG., ThompsonJ. A., FangB., and LiuJ.Silencing of H-ras Gene Expression by Retrovirus-mediated siRNA Decreases Transformation Efficiency and Tumor Growth in a Model of Human Ovarian Cancer. Oncogene22, 5694–5701 (2003).
23.
StoreyJ. D. and TibshiraniR.Statistical Significance for Genome-wide Studies. Proc Natl Acad Sci USA100, 9440–9445 (2003).
24.
QiuT. H., ChandramouliG. V., HunterK. W., AlkharoufN. W., GreenJ. E., and LiuE. T.Global Expression Profiling Identifies Signatures of Tumor Virulence in MMTV-PyMT-transgenic Mice: Correlation to Human Disease. Cancer Res64, 5973–5981 (2004).
25.
LiuB. Y., McDermottS. P., KhwajaS. S., and AlexanderC. M.The Transforming Activity of Wnt Effectors Correlates with Their Ability to Induce the Accumulation of Mammary Progenitor Cells. Proc Natl Acad Sci USA101, 4158–4163 (2004).
26.
ShackletonM., VaillantF., SimpsonK. J., StinglJ., SmythG. K., Asselin-LabatM. L., WuL., LindemanG. J., and VisvaderJ. E.Generation of a Functional Mammary Gland from a Single Stem Cell. Nature439, 84–88 (2006).
27.
RosnerA., MiyoshiK., Landesman-BollagE., XuX., SeldinD. C., MoserA. R., MacLeodC. L., ShyamalaG., GillgrassA. E., and CardiffR. D.Pathway Pathology: Histological Differences Between ErbB/Ras and Wnt Pathway Transgenic Mammary Tumors. Am J Pathol161, 1087–1097 (2002).
28.
CuiX. S. and DonehowerL. A.Differential Gene Expression in Mouse Mammary Adenocarcinomas in the Presence and Absence of Wild Type p53. Oncogene19, 5988–5996 (2000).
29.
ZhangX., PodsypaninaK., HuangS., MohsinS. K., ChamnessG. C., HatsellS., CowinP., SchiffR., and LiY.Estrogen Receptor Positivity in Mammary Tumors of Wnt-1 Transgenic Mice is Influenced by Collaborating Oncogenic Mutations. Oncogene24, 4220–4231 (2005).
30.
HenryM. D., TriplettA. A., OhK. B., SmithG. H., and WagnerK. U.Parity-induced Mammary Epithelial Cells Facilitate Tumorigenesis in MMTV-neu Transgenic Mice. Oncogene23, 6980–6985 (2004).
31.
WangY., WuR., ChoK. R., SheddenK. A., BarderT. J., and LubmanD. M.Classification of Cancer Cell Lines Using an Automated Two-dimensional Liquid Mapping Method with Hierarchical Clustering Techniques. Mol Cell Proteomics5, 43–52 (2006).
32.
LuJ., GetzG., MiskaE. A., Alvarez-SaavedraE., LambJ., PeckD., Sweet-CorderoA., EbertB. L., MakR. H., FerrandoA. A., DowningJ. R., JacksT., HorvitzH. R., and GolubT. R.MicroRNA Expression Profiles Classify Human Cancers. Nature435, 834–838 (2005).
